Cannabis And Cannabinoid Research
84 researchers across 6 institutions
Research in cannabis and cannabinoids explores the complex interactions between cannabis compounds and biological systems. Investigations examine the pharmacological effects of cannabinoids, including their potential therapeutic applications and associated toxicological profiles. Studies employ diverse methodologies, from molecular and cellular assays to clinical trials and population health analyses, to understand mechanisms of action, identify optimal dosing, and assess safety. This field also investigates the behavioral and psychological impacts of cannabis use, contributing to substance abuse treatment strategies and mental health interventions.
This research holds particular relevance for Arkansas. The state's emerging regulated cannabis market creates opportunities for scientific inquiry into product efficacy, safety, and economic impact. Understanding the public health implications of cannabis use, including potential effects on mental health and substance abuse patterns within Arkansas communities, is a key focus. Furthermore, research into agricultural aspects of cannabis cultivation can inform best practices for Arkansas farmers and contribute to the state's agricultural economy.
This interdisciplinary area draws on expertise from pharmacology, toxicology, public health, neuroscience, behavioral science, and agricultural sciences. Engagement spans multiple Arkansas institutions, fostering collaborative approaches to address critical questions about cannabis and cannabinoids.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Lei Guo | NCTR | 52 | 18,086 | High Impact | |
| Matthew T. Feldner | University of Arkansas | 51 | 7,740 | High Impact | |
| Jerry W. King | University of Arkansas | 48 | 7,024 | ||
| William E. Fantegrossi | UAMS | 41 | 5,170 | Grant PI High Impact | |
| Anna Radomińska‐Pandya | UAMS | 40 | 6,029 | High Impact | |
| Paul L. Prather | UAMS | 39 | 4,718 | Grant PI | |
| Ellen W. Leen‐Feldner | University of Arkansas | 36 | 3,531 | High Impact | |
| Jeffery H. Moran | UAMS | 29 | 3,769 | High Impact | |
| Erica L. Liebelt | UAMS | 28 | 2,302 | ||
| Ali S. Taha | UAMS | 26 | 3,133 | High Impact | |
| Thaddeus Bartter | UAMS | 25 | 2,441 | High Impact | |
| Linda S. Von Tungeln | NCTR | 25 | 2,024 | High Impact | |
| Brett Adams | UAMS | 25 | 2,645 | High Impact | |
| Alicia M. Allen | UAMS | 24 | 1,895 | High Impact | |
| Michelle M. Vanlandingham | NCTR | 23 | 1,727 | High Impact | |
| Eric U. Yee | UAMS | 22 | 1,577 | High Impact | |
| Qiangen Wu | NCTR | 21 | 1,145 | High Impact | |
| Yuxi Li | NCTR | 19 | 1,322 | ||
| Laura Ewing | UAMS | 17 | 1,023 | ||
| Silvia Marino | UAMS | 17 | 743 |
Related Research Areas
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Johns Hopkins University 1,298
- 2 Harvard University 1,240
- 3 National Institutes of Health 1,061
- 4 Yale University 963
- 5 Columbia University 945
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Cannabis And Cannabinoid Research.